EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report

Timothy Mark Earls Davis

American Journal of Case Reports · 2024

DOI: 10.12659/ajcr.946539 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Case Reports, 2024. Verfasst von Timothy Mark Earls Davis. Beteiligte Einrichtung: Medical School, University of Western Australia, Fremantle, Western Australia, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Hypocalcemia, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucagon-Like PeptidesHypocalcemiaHypoglycemic AgentsHumansFemaleAgedMagnesium DeficiencyMagnesiumSemaglutide

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsMagnesiumSemaglutide

Autor:innen und Institutionen

  • Medical School, University of Western Australia, Fremantle, Western Australia, Australia.
  • Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals, Murdoch, Western Australia, Australia.

Zitieren

APA

Davis, T. M. E. (2024). Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report. American Journal of Case Reports. https://doi.org/10.12659/ajcr.946539

Vancouver

Davis TME. Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report. American Journal of Case Reports. 2024. doi:10.12659/ajcr.946539

BibTeX
@article{Davis2024,
  author = {Davis, Timothy Mark Earls},
  title = {Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report},
  journal = {American Journal of Case Reports},
  year = {2024},
  doi = {10.12659/ajcr.946539}
}
Kostenlos starten →